Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 898,215	$ 575,422
Accounts receivable	1,184,105	875,914
Inventories	1,238,034	3,423,420
Prepaids and other current assets	1,045,949	1,444,593
Total current assets	4,366,303	6,319,349
Long-term assets
Restricted cash	638,639	635,498
Property, plant and equipment, net	1,911,668	2,003,887
Financing lease right-of-use asset	26,144	13,302
Operating lease right-of-use asset	2,567,532	709,883
Goodwill	1,384,255	1,384,255
Patents and other intangibles, net	4,067,317	4,190,621
Total long-term assets	10,595,555	8,937,446
Total assets	14,961,858	15,256,795
Current liabilities
Accounts payable	2,271,349	4,229,128
Accrued liabilities	1,195,773	1,096,090
Unearned revenue	1,198,910	1,240,205
Current portion of operating lease right-of-use liability	83,862	100,777
Current portion of financing lease liability	7,608	2,367
Current installments of notes payable	471,809	1,519,496
Total current liabilities	5,229,311	8,188,063
Long-term liabilities
Obligation for lease disposal costs	577,434	546,570
Related party notes payable, net of debt discount	1,026,640	1,216,874
Notes payable, net of current portion	5,506	12,276
Financing lease liability, net of current portion	18,902	10,970
Operating lease right-of-use liability, net of current portion	2,506,531	609,106
Mandatorily redeemable convertible preferred stock, net of discount	4,881,337	4,785,086
Total long-term liabilities	9,016,350	7,180,882
Total liabilities	14,245,661	15,368,945
Commitments and contingencies
Stockholders' (Deficit) Equity
Common stock	4,242,727	4,198,423
Additional paid-in capital	122,181,532	121,680,163
Accumulated deficit	(127,950,501)	(128,064,385)
Deficit attributable to International Isotopes Inc. stockholders	(1,526,242)	(2,185,799)
Equity attributable to noncontrolling interest	2,242,439	2,073,649
Total equity (deficit)	716,197	(112,150)
Total liabilities and stockholders' equity (deficit)	$ 14,961,858	$ 15,256,795